Osteoporosis Research Today is a free monthly online journal that collates and summarizes the latest research about Osteoporosis, including details on symptoms, treatment, prevention, causes.

Volume 2 (2005), Issue 5 (May)

1. Severity of obstructive airway disease and risk of osteoporotic fracture.
   Eur Respir J, 25(5): 879-84. [Abstract] [Full-text]
2. Preliminary outcomes and efficacy of the first 360 consecutive kyphoplasties for the treatment of painful osteoporotic vertebral compression fractures.
   Spine J, 5(3): 244-55. [Abstract] [Full-text]
3. Hydroxyapatite-coating of pedicle screws improves resistance against pull-out force in the osteoporotic canine lumbar spine model: a pilot study.
   Spine J, 5(3): 239-43. [Abstract] [Full-text]
4. The identification of osteoporosis in patients presenting with low-impact fracture: a pilot study of a method for identification of these patients.
   Accid Emerg Nurs, 13(2): 126-9. [Abstract] [Full-text]
5. Ipriflavone modulates IGF-I but is unable to restore bone in rats.
   Phytother Res, 19(2): 116-20. [Abstract] [Full-text]
6. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density.
   Bone, 36(5): 917-25. [Abstract] [Full-text]
7. Bone histomorphometry in 22 male patients with normocalciuric idiopathic osteoporosis.
   Bone, 36(5): 926-30. [Abstract] [Full-text]
8. Menopausal hormone therapy: currently no evidence for cardiac protection.
   Pediatr Blood Cancer, 44(7): 625-9. [Abstract] [Full-text]
9. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
   Calcif Tissue Int, 76(3): 176-86. [Abstract] [Full-text]
10. Ascorbic acid deficiency, iron overload and alcohol abuse underlie the severe osteoporosis in black African patients with hip fractures--a bone histomorphometric study.
    Calcif Tissue Int, 76(2): 79-89. [Abstract] [Full-text]
11. Bone mineral density and the risk of incident nonspinal fractures in black and white women.
    JAMA, 293(17): 2102-8. [Abstract] [Full-text]
12. Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis.
    J Eval Clin Pract, 11(3): 247-55. [Abstract] [Full-text]
13. Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fracture.
    Osteoporos Int, 16(5): 483-9. [Abstract] [Full-text]
14. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.
    Osteoporos Int, 16(5): 475-82. [Abstract] [Full-text]
15. Hip fracture in women without osteoporosis.
    J Clin Endocrinol Metab, 90(5): 2787-93. [Abstract] [Full-text]
16. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
    J Clin Endocrinol Metab, 90(5): 2816-22. [Abstract] [Full-text]
17. Contributions of bone density and structure to fracture risk assessment in men and women.
    Osteoporos Int, 16(5): 460-7. [Abstract] [Full-text]
18. Quality of life in patients with osteoporosis.
    Osteoporos Int, 16(5): 447-55. [Abstract] [Full-text]
19. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos).
    Osteoporos Int, 16(5): 568-78. [Abstract] [Full-text]
20. Forearm bone mineral density in an unselected population of 2,779 men and women--the HUNT Study, Norway.
    Osteoporos Int, 16(5): 562-7. [Abstract] [Full-text]
21. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women.
    Osteoporos Int, 16(5): 468-74. [Abstract] [Full-text]
22. Bone mineral density measurement in the calcaneus with DXL: comparison with hip and spine measurements in a cross-sectional study of an elderly female population.
    Osteoporos Int, 16(5): 541-51. [Abstract] [Full-text]
23. Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone.
    Osteoporos Int, 16: S36-43. [Abstract] [Full-text]
24. Clinical utility of laboratory testing in women with osteoporosis.
    Osteoporos Int, 16(5): 534-40. [Abstract] [Full-text]
25. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy.
    Osteoporos Int, 16(5): 510-6. [Abstract] [Full-text]
26. Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study.
    Osteoporos Int, 16(5): 490-500. [Abstract] [Full-text]
27. Idiopathic osteoporosis in premenopausal women.
    Osteoporos Int, 16(5): 526-33. [Abstract] [Full-text]
28. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.
    Adv Drug Deliv Rev, 57(7): 973-93. [Abstract] [Full-text]
29. Quest for the Holy Grail to cure arthritis and osteoporosis: emphasis on bone drug delivery systems.
    Adv Drug Deliv Rev, 57(7): 939-44. [Abstract] [Full-text]
30. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
    J Bone Miner Res, 20(6): 971-6. [Abstract] [Full-text]
31. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    J Bone Miner Res, 20(6): 962-70. [Abstract] [Full-text]
32. Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
    J Bone Miner Res, 20(6): 898-905. [Abstract] [Full-text]
33. Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study.
    Rheumatol Int, 25(4): 296-300. [Abstract] [Full-text]
34. Barriers to providing osteoporosis care in skilled nursing facilities: perceptions of medical directors and directors of nursing.
    J Am Med Dir Assoc, 6(3): S61-6. [Abstract] [Full-text]
35. Evaluation of osteoporosis in X-ray CT examination: a preliminary study for an automatic recognition algorithm for the central part of a vertebral body using abdominal X-ray CT images.
    Comput Med Imaging Graph, 29(4): 259-66. [Abstract] [Full-text]
36. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
    Womens Health Issues, 15(3): 97-108. [Abstract] [Full-text]
37. Osteogenic PTHs and vascular ossification-Is there a danger for osteoporotics?
    J Cell Biochem, 95(3): 437-44. [Abstract] [Full-text]
38. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    J Heart Lung Transplant, 24(5): 526-32. [Abstract] [Full-text]
39. Osteoporosis therapy: an example of putting evidence-based medicine into clinical practice.
    QJM, 98(6): 403-13. [Abstract] [Full-text]
40. The high prevalence of inadequate serum vitamin D levels and implications for bone health.
    Curr Med Res Opin, 21(4): 579-86. [Abstract] [Full-text]
41. How useful are measures of BMD and bone turnover?
    Curr Med Res Opin, 21(4): 545-54. [Abstract] [Full-text]
42. Closing the osteoporosis management gap in primary care: a secondary prevention of fracture programme.
    Curr Med Res Opin, 21(4): 475-82. [Abstract] [Full-text]
43. Fragility fractures of the ankle: stabilisation with an expandable calcaneotalotibial nail.
    J Bone Joint Surg Br, 87(6): 809-13. [Abstract] [Full-text]
44. Osteoporosis.
    Clin Geriatr Med, 21(3): 603-29, viii. [Abstract] [Full-text]
45. Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density.
    Eur J Hum Genet, 13(6): 781-8. [Abstract] [Full-text]
46. Impact of a community-based osteoporosis and fall prevention program on fracture incidence.
    Osteoporos Int, 16(6): 700-6. [Abstract] [Full-text]
47. Bone mineral density and five prominent candidate genes in Chinese men: associations, interaction effects and their implications.
    Maturitas, 51(2): 199-206. [Abstract] [Full-text]
48. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.
    Maturitas, 51(2): 177-86. [Abstract] [Full-text]
49. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Maturitas, 51(2): 113-26. [Abstract] [Full-text]
50. The use of fingernails as a means of assessing bone health: a pilot study.
    J Womens Health (Larchmt), 14(4): 339-44. [Abstract] [Full-text]
51. Setting educational priorities for women's preventive health: measuring beliefs about screening across disease states.
    J Womens Health (Larchmt), 14(4): 324-30. [Abstract] [Full-text]
52. Raloxifene and colorectal cancer.
    J Womens Health (Larchmt), 14(4): 299-305. [Abstract] [Full-text]
53. Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women.
    J Clin Endocrinol Metab, 90(6): 3491-7. [Abstract] [Full-text]
54. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.
    J Clin Endocrinol Metab, 90(6): 3215-24. [Abstract] [Full-text]
55. Low bone formation in premenopausal women with idiopathic osteoporosis.
    J Clin Endocrinol Metab, 90(6): 3331-6. [Abstract] [Full-text]
56. Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial.
    J Clin Endocrinol Metab, 90(6): 3209-14. [Abstract] [Full-text]
57. Fracture risk in patients with prostate cancer on androgen deprivation therapy.
    Osteoporos Int, 16(6): 707-11. [Abstract] [Full-text]
58. Assessment of fracture risk.
    Osteoporos Int, 16(6): 581-9. [Abstract] [Full-text]
59. A model of osteoporosis impact in Switzerland 2000-2020.
    Osteoporos Int, 16(6): 659-71. [Abstract] [Full-text]
60. Hand workload and the metacarpal cortical index. a study of middle-aged teachers and dentists.
    Osteoporos Int, 16(6): 672-80. [Abstract] [Full-text]
61. Calcaneum broadband ultrasound attenuation relates to vegetarian and omnivorous diets differently in men and women: an observation from the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.
    Osteoporos Int, 16(6): 590-6. [Abstract] [Full-text]
62. Bone density and hemoglobin levels in older persons: results from the InCHIANTI study.
    Osteoporos Int, 16(6): 691-9. [Abstract] [Full-text]
63. Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong).
    Osteoporos Int, 16(6): 610-5. [Abstract] [Full-text]
64. Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population.
    Osteoporos Int, 16(6): 603-9. [Abstract] [Full-text]
65. Relationship between immunosuppression and osteoporosis in an outpatient liver transplant clinic.
    Transplant Proc, 37(4): 1910-1. [Abstract] [Full-text]
66. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
    Clin Ther, 27(4): 361-76. [Abstract] [Full-text]
67. Osteoporosis in systemic lupus erythematosus mechanisms.
    Rheum Dis Clin North Am, 31(2): 363-85, viii. [Abstract] [Full-text]
68. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
    Am J Hypertens, 18(6): 797-804. [Abstract] [Full-text]

© 2004-2008 Osteoporosis Research Today. All Rights Reserved.